Skip to content
10-Q

Quarterly Report

NEUROCRINE BIOSCIENCES INC NBIX

0000914475-25-000158

← back to feed
Filed
Jul 30, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Jul 24, 2025 99.18M sh
Shares Diluted Q2 2025 · Jun 30, 2025 101M sh
Shares Diluted Q2 2025 · Jun 30, 2025 101.8M sh
Shares Diluted Q2 2025 · Jun 30, 2024 103.9M sh
Shares Diluted Q2 2025 · Jun 30, 2024 103.8M sh
Stock Repurchased Q2 2025 · Jun 30, 2025 $167.7M
Stock Repurchased Q2 2025 · Jun 30, 2024 $0
Capex Q2 2025 · Jun 30, 2025 $23.2M
Capex Q2 2025 · Jun 30, 2024 $22.8M
Operating Cash Flow Q2 2025 · Jun 30, 2025 $166.8M
Operating Cash Flow Q2 2025 · Jun 30, 2024 $194.9M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $264M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $233M
Cash And Equivalents Q2 2025 · Jun 30, 2024 $139.7M
Stockholders Equity Q2 2025 · Jun 30, 2025 $2.69B
Stockholders Equity Q2 2025 · Mar 31, 2025 $2.54B
Stockholders Equity Q2 2025 · Dec 31, 2024 $2.59B
Stockholders Equity Q2 2025 · Jun 30, 2024 $2.51B
Stockholders Equity Q2 2025 · Mar 31, 2024 $2.39B
Stockholders Equity Q2 2025 · Dec 31, 2023 $2.23B
Current Liabilities Q2 2025 · Jun 30, 2025 $546.3M
Current Liabilities Q2 2025 · Dec 31, 2024 $507.7M
Total Liabilities Q2 2025 · Jun 30, 2025 $1.2B
Total Liabilities Q2 2025 · Dec 31, 2024 $1.13B
Current Assets Q2 2025 · Jun 30, 2025 $1.75B
Current Assets Q2 2025 · Dec 31, 2024 $1.72B
Total Assets Q2 2025 · Jun 30, 2025 $3.89B
Total Assets Q2 2025 · Dec 31, 2024 $3.72B
Eps Diluted Q2 2025 · Jun 30, 2025 $1.06
Eps Diluted Q2 2025 · Jun 30, 2025 $1.13
Eps Diluted Q2 2025 · Jun 30, 2024 $0.63
Eps Diluted Q2 2025 · Jun 30, 2024 $1.04
Eps Basic Q2 2025 · Jun 30, 2025 $1.09
Eps Basic Q2 2025 · Jun 30, 2025 $1.16
Eps Basic Q2 2025 · Jun 30, 2024 $0.64
Eps Basic Q2 2025 · Jun 30, 2024 $1.08
Sga Expense Q2 2025 · Jun 30, 2025 $286.3M
Sga Expense Q2 2025 · Jun 30, 2025 $562.8M
Sga Expense Q2 2025 · Jun 30, 2024 $242M
Sga Expense Q2 2025 · Jun 30, 2024 $485.1M
Net Income Q2 2025 · Jun 30, 2025 $107.5M
Net Income Q2 2025 · Jun 30, 2025 $115.4M
Net Income Q2 2025 · Jun 30, 2024 $65M
Net Income Q2 2025 · Jun 30, 2024 $108.4M
Operating Income Q2 2025 · Jun 30, 2025 $145.6M
Operating Income Q2 2025 · Jun 30, 2025 $169.2M
Operating Income Q2 2025 · Jun 30, 2024 $145.4M
Operating Income Q2 2025 · Jun 30, 2024 $244.7M
Cost Of Revenue Q2 2025 · Jun 30, 2025 $11.3M
Cost Of Revenue Q2 2025 · Jun 30, 2025 $20.5M
Cost Of Revenue Q2 2025 · Jun 30, 2024 $9.2M
Cost Of Revenue Q2 2025 · Jun 30, 2024 $16.7M
Revenue Q2 2025 · Jun 30, 2025 $687.5M
Revenue Q2 2025 · Jun 30, 2025 $1.26B
Revenue Q2 2025 · Jun 30, 2024 $590.2M
Revenue Q2 2025 · Jun 30, 2024 $1.11B